local_hospital

Frauenarzt-Praxis Erwin Göckeler-Leopold

Address
Kleiner Hellweg 5, 59590 Geseke, Germany

Female Urogenital Diseases and Pregnancy Complications

The practice is conducting studies aimed at improving care for post‑menopausal women with vaginal atrophy. One trial evaluates a novel estriol‑releasing vaginal ring across three dose levels, assessing changes in the vaginal epithelium, pH balance and systemic hormone exposure over 90 days.

  • Dose‑finding and proof‑of‑concept for estriol vaginal ring
  • Cytologic pattern evaluation of vaginal epithelium
  • Monitoring of vaginal pH changes
  • Pharmacokinetic profiling of systemic estriol

Frauenarzt‑Praxis Erwin Göckeler‑Leopold supports research that may offer safer, more effective options for managing menopause‑related urogenital symptoms.

Skin and Connective Tissue Diseases

The site is evaluating a new topical preparation that combines clotrimazole with betamethasone dipropionate for patients suffering from moderately to severely inflamed candidiasis of the skin. The study compares this ointment to an authorized product and a vehicle to determine therapeutic benefit and safety.

  • Efficacy comparison with Lotricomb® ointment
  • Safety assessment of combined antifungal‑steroid formulation
  • Resolution of skin inflammation and symptom relief
  • Evaluation of vehicle effects without active ingredients

With a single experienced investigator, the practice aims to enhance treatment options for fungal skin infections.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
3
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
2
Outperforms 47% of sites
public
Therapeutic diversity
2areas
Outperforms 62% of sites
groups
Sponsor diversity
2sponsors
Outperforms 51% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Frauenarzt-Praxis Erwin Göckeler-Leopold

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Double-blind, randomised clinical study comparing efficacy and safety of Mecloderm® Ointment (Test) vs. Lotricomb® Ointment (Reference) vs. Vehicle in patients with moderate to severely inflamed candidiasis of the skinDermapharm AGPhase IIIRecruitingMar 2022

IMP list

lock Showing 1 of 3 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Betamethasone Dipropionate1Unknown2022-03-082022-03-08

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.